Drug Discontinuation Requirements Would Be Expanded Under DeWine Bill
Executive Summary
Manufacturers that intend to discontinue drugs or biologics would have to notify FDA even if the products to be discontinued are multi-source, under a bill introduced by Sen. Mike DeWine (D-Ohio)
You may also be interested in...
FDA Evaluating Vaccine GMP Requirements To Assess Impact on Supply
FDA is re-evaluating its approach to good manufacturing practices, FDA Acting Commissioner Lester Crawford, PhD, suggested during a June 12 hearing on vaccine supply
FDA Evaluating Vaccine GMP Requirements To Assess Impact on Supply
FDA is re-evaluating its approach to good manufacturing practices, FDA Acting Commissioner Lester Crawford, PhD, suggested during a June 12 hearing on vaccine supply
Vaccine Supply Would Be Monitored By HHS Unit Under Rep. Crowley Bill
A vaccine oversight agency within HHS would be established under a bill introduced by Rep. Joseph Crowley (D-N.Y.)